Edwardsiella Tarda Antibody (236/128) [Janelia Fluor® 549]

• Reactivity: Ba
• Applications: ELISA
• Clone: 236/128
• Clonality: Monoclonal
• Host: Mouse
• Conjugate: Janelia Fluor 549

Edwardsiella Tarda Antibody (236/128) [Janelia Fluor® 549] Summary

• Immunogen: Native
• Specificity: This product recognizes Edwardsiella tarda. E. tarda is a member of the family Enterobactericeae associated with freshwater ecosystems that that can cause gastoenteritis, wound infections and death due to septicaemia. It is thought that the pathogenicity of this bacteria is due to it's ability to resist phagocytic killing by the host defences. Studies show that replication of E. tarda in murine macrophages is dependant on the type III secretion system and induces an anti-apoptotic effect by up-regulating anti-apoptotic NF-kB target genes.
• Isotype: IgG1
• Clonality: Monoclonal
• Host: Mouse
• Purity: Protein G purified

Applications/Dilutions

• Dilutions:
  • ELISA
• Application Notes: Optimal dilution of this antibody should be experimentally determined.

Reactivity Notes

0

Packaging, Storage & Formulations

• Storage: Store at 4C in the dark.
• Buffer: 50mM Sodium Borate
• Preservative: 0.05% Sodium Azide
• Purity: Protein G purified

Notes

Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.

Alternate Names for Edwardsiella Tarda Antibody (236/128) [Janelia Fluor® 549]

• aracolobactrum anguillimortiferum
• Edwardsiella anguillimortifera

Background

Edwardsiella tarda is a member of the family Enterobactericeae associated with freshwater ecosystems that that can cause gastoenteritis, wound infections and death due to septicaemia. It is thought that the pathogenicity of this bacteria is due to it's ability to resist phagocytic killing by the host defences. Studies show that replication of E. tarda in murine macrophages is dependant on the type III secretion system and induces an anti-apoptotic effect by up-regulating anti-apoptotic NFkB target genes.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.